Literature DB >> 28529601

Identification of breast cancer prognostic modules based on weighted protein-protein interaction networks.

Wan Li1, Xue Bai1, Erqiang Hu1, Hao Huang1, Yiran Li1, Yuehan He1, Junjie Lv1, Lina Chen1, Weiming He2.   

Abstract

Breast cancer is one of the leading causes of mortality in females. A number of prognostic markers have been identified, including single genes, multi-gene signatures and network modules; however, the robustness of these prognostic markers is insufficient. Thus, the present study proposed a more robust method to identify breast cancer prognostic modules based on weighted protein-protein interaction networks, by integrating four sets of disease-associated expression profiles. Three identified prognostic modules were closely associated with prognosis-associated functions and survival time, as determined by Cox regression and Kaplan-Meier survival analyses. The robustness of these modules was verified with an independent profile from another platform. Genes from these modules may be useful as breast cancer prognostic markers. The prognostic modules could be used to determine the prognoses of patients with breast cancer and characterize patient recovery.

Entities:  

Keywords:  breast cancer; prognosis; prognostic modules; robustness; survival analysis

Year:  2017        PMID: 28529601      PMCID: PMC5434807          DOI: 10.3892/ol.2017.5917

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  39 in total

1.  p53, mitosis, apoptosis and necrosis as prognostic indicators of long-term survival in breast cancer.

Authors:  Takao Kato; Shingo Kameoka; Tsunehito Kimura; Shinichi Tanaka; Toshio Nishikawa; Makio Kobayashi
Journal:  Anticancer Res       Date:  2002 Mar-Apr       Impact factor: 2.480

2.  Detecting overlapping protein complexes in protein-protein interaction networks.

Authors:  Tamás Nepusz; Haiyuan Yu; Alberto Paccanaro
Journal:  Nat Methods       Date:  2012-03-18       Impact factor: 28.547

3.  Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance.

Authors:  Maggie C Louie; Ashley McClellan; Christina Siewit; Lauren Kawabata
Journal:  Mol Cancer Res       Date:  2010-03-09       Impact factor: 5.852

Review 4.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

5.  Proteomic snapshot of breast cancer cell cycle: G1/S transition point.

Authors:  Milagros J Tenga; Iulia M Lazar
Journal:  Proteomics       Date:  2013-01       Impact factor: 3.984

6.  Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer.

Authors:  Maureen Cronin; Chithra Sangli; Mei-Lan Liu; Mylan Pho; Debjani Dutta; Anhthu Nguyen; Jennie Jeong; Jenny Wu; Kim Clark Langone; Drew Watson
Journal:  Clin Chem       Date:  2007-04-26       Impact factor: 8.327

7.  Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.

Authors:  Yudi Pawitan; Judith Bjöhle; Lukas Amler; Anna-Lena Borg; Suzanne Egyhazi; Per Hall; Xia Han; Lars Holmberg; Fei Huang; Sigrid Klaar; Edison T Liu; Lance Miller; Hans Nordgren; Alexander Ploner; Kerstin Sandelin; Peter M Shaw; Johanna Smeds; Lambert Skoog; Sara Wedrén; Jonas Bergh
Journal:  Breast Cancer Res       Date:  2005-10-03       Impact factor: 6.466

8.  PROGgene: gene expression based survival analysis web application for multiple cancers.

Authors:  Chirayu Pankaj Goswami; Harikrishna Nakshatri
Journal:  J Clin Bioinforma       Date:  2013-10-28

9.  Origin licensing requires ATP binding and hydrolysis by the MCM replicative helicase.

Authors:  Gideon Coster; Jordi Frigola; Fabienne Beuron; Edward P Morris; John F X Diffley
Journal:  Mol Cell       Date:  2014-07-31       Impact factor: 17.970

10.  Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines.

Authors:  Manoj B Parmar; Hamidreza Montazeri Aliabadi; Parvin Mahdipoor; Cezary Kucharski; Robert Maranchuk; Judith C Hugh; Hasan Uludağ
Journal:  Front Bioeng Biotechnol       Date:  2015-02-16
View more
  1 in total

1.  LncRNA ENST869 Targeting Nestin Transcriptional Region to Affect the Pharmacological Effects of Chidamide in Breast Cancer Cells.

Authors:  Xiuyan Feng; Han Han; Yarui Guo; Xue Feng; Shanchun Guo; Weiqiang Zhou
Journal:  Front Oncol       Date:  2022-04-04       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.